Butterfly Network, Inc.
BFLYNYSEHealthcare · X-Ray Apparatus & Tubes & Related Irradiation Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $97.6M | $82.1M | $65.9M | $73.4M | $62.6M | $46.3M |
| Operating income | −$86.4M | −$74.4M | −$145.6M | −$193.0M | −$192.7M | −$161.6M |
| Net income | −$77.1M | −$72.5M | −$133.7M | −$168.7M | −$32.4M | −$162.7M |
| Total assets | $296.5M | $256.1M | $304.3M | $417.6M | $572.0M | $147.2M |
| Total liabilities | $100.6M | $87.3M | $84.2M | $92.2M | $124.3M | $148.2M |
| Equity | $196.0M | $168.8M | $220.1M | $325.4M | $447.7M | −$361.9M |
| EPS (diluted) | $-0.31 | $-0.34 | $-0.65 | $-0.84 | $-0.19 | $-26.87 |
| Shares out. | 247.1M | 211.7M | 205.4M | 199.8M | 173.8M | 6.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −88.5%
- Net margin
- −79.0%
- Return on equity
- −39.3%
- Return on assets
- −26.0%
- Return on capital (ROCE)
- −37.3%
- Liabilities / assets
- 33.9%
- Debt / equity
- 0.51×
- Book value / share
- $0.79
- Revenue growth (YoY)
- 19.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -5.51distress
- Accruals / assets
- −21.7%clean
- Beneish M-Score
- -3.23normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 3 warning● 3 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Group IncPassive (13G)Mar 26, 2026
- Rothberg Jonathan MActivist (13D)Mar 17, 2026
- Glenview Capital Management, LlcActivist (13D)Feb 17, 2026
- Fosun Industrial Co., LtdPassive (13G)Feb 5, 2026
- Blackrock, Inc.Passive (13G)Jul 17, 2025
- Ark Investment Management LlcPassive (13G)Jan 10, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 25.0M | 5.0 | +3.4% |
| Apr 30, 2026 | 24.1M | 3.5 | -3.6% |
| Apr 15, 2026 | 25.0M | 7.4 | -0.1% |
| Mar 31, 2026 | 25.1M | 5.6 | -3.2% |
| Mar 13, 2026 | 25.9M | 5.3 | -12.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Director / officer changeMay 8, 2026
- Results of operationsApr 30, 2026
- Results of operationsFeb 26, 2026
- Delisting / listing-standard noticeJan 14, 2026
- Results of operationsJan 12, 2026
- Entered a material agreementNov 18, 2025
- Results of operationsOct 31, 2025
- Director / officer change · Regulation FD disclosureOct 9, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMay 21, 2026
- 3INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIESMay 21, 2026
- 8-KMay 8, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMay 5, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMay 1, 2026
- 144May 1, 2026
- 10-QApr 30, 2026
- 8-KApr 30, 2026
- 144Apr 29, 2026
- ARSApr 27, 2026
- DEFA14AApr 27, 2026
- DEF 14AApr 27, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESApr 17, 2026
- 144Apr 16, 2026
- SCHEDULE 13G/AMar 26, 2026
Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.